Back to search

Article

Dual G9A and EZH2 inhibition stimulates an anti-tumour immune response in ovarian high-grade serous carcinoma

2021-05-11

Abstract excerpt

Ovarian high-grade serous carcinoma (HGSC) prognosis correlates directly with presence of intratumoral lymphocytes. However, cancer immunotherapy has yet to achieve meaningful survival benefit in patients with HGSC. Epigenetic silencing of immunostimulatory genes is implicated in immune evasion in HGSC and re-expression of these genes could promote tumour immune clearance. We discovered that simultaneous inhibitio...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
798ad205-e2e0-58e1-96da-fbbf61809a3a
DOI
10.1101/2021.05.09.443282
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Dual G9A and EZH2 inhibition stimulates an anti-tumour immune response in ovarian high-grade serous carcinomaDOI 10.1101/2021.05.09.443282
Select a neighboring publication to make it the new centre.